EGFR and non-small cell lung carcinoma: In our study, targeted NGS assay and the single-gene qPCR test showed 76.14% concordance rate (Cohen’s Kappa = 0.60) in detection of actionable EGFR variants in clinical tumor tissue specimens from 59 advanced NSCLC patients.